Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 2
1997 2
2000 1
2002 2
2003 2
2004 3
2005 1
2007 2
2008 1
2010 2
2011 2
2012 4
2013 2
2014 3
2015 2
2016 1
2017 2
2018 7
2019 3
2020 15
2021 10
2022 15
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Established Rheumatoid Arthritis.
Ortiz AM, Ataman S. Ortiz AM, et al. Among authors: ataman s. Best Pract Res Clin Rheumatol. 2019 Oct;33(5):101483. doi: 10.1016/j.berh.2019.101483. Epub 2020 Jan 28. Best Pract Res Clin Rheumatol. 2019. PMID: 32001169 No abstract available.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
Beyond expectations: disease duration and psychological burden in psoriatic arthritis.
Kılıç G, Kılıç E, Tekeoğlu İ, Sargın B, Cengiz G, Balta NC, Alkan H, Kasman SA, Şahin N, Orhan K, Gezer İA, Keskin D, Mülkoğlu C, Reşorlu H, Ataman Ş, Bal A, Duruöz MT, Küçükakkaş O, Şen N, Toprak M, Yurdakul OV, Melikoğlu MA, Ayhan FF, Baykul M, Bodur H, Çalış M, Çapkın E, Devrimsel G, Hizmetli S, Kamanlı A, Keskin Y, Ecesoy H, Kutluk Ö, Şendur ÖF, Tolu S, Tuncer T, Nas K. Kılıç G, et al. Among authors: ataman s. Rheumatol Int. 2023 Sep;43(9):1695-1704. doi: 10.1007/s00296-023-05379-2. Epub 2023 Jul 7. Rheumatol Int. 2023. PMID: 37418001
Diagnostic delay in psoriatic arthritis: insights from a nationwide multicenter study.
Kılıç G, Kılıç E, Tekeoğlu İ, Sargın B, Cengiz G, Balta NC, Alkan H, Kasman SA, Şahin N, Orhan K, Gezer İA, Keskin D, Mülkoğlu C, Reşorlu H, Ataman Ş, Bal A, Duruöz MT, Kücükakkaş O, Şen N, Toprak M, Yurdakul OV, Melikoğlu MA, Ayhan FF, Baykul M, Bodur H, Çalış M, Çapkın E, Devrimsel G, Hizmetli S, Kamanlı A, Keskin Y, Ecesoy H, Kutluk Ö, Şendur ÖF, Tolu S, Tuncer T, Nas K. Kılıç G, et al. Among authors: ataman s. Rheumatol Int. 2023 Oct 8. doi: 10.1007/s00296-023-05479-z. Online ahead of print. Rheumatol Int. 2023. PMID: 37805980
Subclinical cardiac disease in ankylosing spondylitis.
Ozen S, Ozen A, Unal EU, Tufekcioglu O, Ataman S, Yalcin AP. Ozen S, et al. Among authors: ataman s. Echocardiography. 2018 Oct;35(10):1579-1586. doi: 10.1111/echo.14103. Epub 2018 Jul 29. Echocardiography. 2018. PMID: 30058250
81 results